Skye Bioscience Inc (SKYE) Company Profile & Statistics

Skye Bioscience Inc
SKYE
(Nasdaq - US)
Closed
5.33
-0.11 (-2.02%)
in:usd•As of: Nov 05, 2024 15:59 UTC -5
Open
5.36
High
5.36
Low
5.06

About Skye Bioscience Inc

CEO

Punit Dhillon

Headquarters

11250 el camino real, suite 100

san diego, ca 92130, united states

Auditor

Marcum LLP

Employees

Share Holders

109

Website

www.skyebioscience.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Skye Bioscience Inc. is a biopharmaceutical company. It is focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need. Skye Bioscience Inc., formerly known as Emerald Bioscience Inc., is based in San Diego, Calif.

Skye Bioscience Inc Statistics

Valuation Measures

Market Capitalization ²	161.71M
Enterprise Value	83.37M
Enterprise Value/EBITDA (ttm)	-1.97
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.14
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-111.83%
Return on Invested Capital (ttm)	-1281.39%
Return on Assets (ttm)	-80.69%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-42.42M
Net Income Avi to Common (ttm)	-42.29M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	1.74
52-Week Change	204.57%
S&P500 52-Week Change	32.45%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	30.34M
Dividend Yield	0.00%
Float ⁴	29.43M
% Held by Insiders	3.00%
% Held by Institutions	21.09%

Balance Sheet

Total Cash (mrq)	83.20M
Total Cash Per Share (mrq)	2.74
Total Debt (mrq)	4.86M
Total Debt/Equity (mrq)	6.67%
Current Ratio (mrq)	6.07%
Quick Ratio (mrq)	6.07%
Book Value Per Share (mrq)	2.59

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.31
Free Cash Flow (ytd)	-10.69M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Skye Bioscience Inc

Trade With A Regulated Broker